Back
Full-text
Journal article

Mechanism of action of the hypnotic zolpidem in vivo.

Show more…
  • 2000-11-23
Published in:
  • British journal of pharmacology. - 2000
Animals
Anticonvulsants
Convulsants
Diazepam
Dose-Response Relationship, Drug
Female
GABA Antagonists
Hypnotics and Sedatives
Male
Mice
Mice, Inbred Strains
Mice, Mutant Strains
Motor Activity
Pentylenetetrazole
Pyridines
Receptors, GABA-A
Zolpidem
English Zolpidem is a widely used hypnotic agent acting at the GABA(A) receptor benzodiazepine site. On recombinant receptors, zolpidem displays a high affinity to alpha 1-GABA(A) receptors, an intermediate affinity to alpha(2)- and alpha(3)-GABA(A) receptors and fails to bind to alpha(5)-GABA(A) receptors. However, it is not known which receptor subtype is essential for mediating the sedative-hypnotic action in vivo. Studying alpha1(H101R) mice, which possess zolpidem-insensitive alpha(1)-GABA(A) receptors, we show that the sedative action of zolpidem is exclusively mediated by alpha(1)-GABA(A) receptors. Similarly, the activity of zolpidem against pentylenetetrazole-induced tonic convulsions is also completely mediated by alpha(1)-GABA(A) receptors. These results establish that the sedative-hypnotic and anticonvulsant activities of zolpidem are due to its action on alpha(1)-GABA(A) receptors and not on alpha(2)- or alpha(3)-GABA(A) receptors.
Language
  • English
Open access status
bronze
Identifiers
Persistent URL
https://folia.unifr.ch/global/documents/161790
Statistics
Document views: 20 File downloads:
  • fulltext.pdf: 0